Rosa Rubicondior: Malevolent Designer News - How The Malaria Parasite Is Cleverly Designed to Maximise Suferring

Plasmodium falciparum parasite.

Malaria’s mRNA: Messages that Mess with the Immune System | Weizmann USA

Research is continually revealing just how efficient the human malaria parasite, Plasmodium falciparum, is at making people sick — and, all too often, killing them. There can be few better examples of the sort of intricate, information-rich biological machinery that Discovery Institute Fellows such as Michael J. Behe and William A. Dembski insist points to an intelligent designer. Although they are careful never to say so plainly, their dog-whistle signals leave their followers in little doubt that this putative designer is meant to be the god of the Bible and Qur’an. That ambiguity gives them enough wriggle-room to tell courts and educators that Intelligent Design is science, not creationism in a lab coat, while still presenting it to supporters as a moral crusade against “Darwinism”.

Now researchers at the Weizmann Institute of Science, in a paper published recently in Cell Reports, have shown yet another reason why this parasite is so successful. Malaria caused an estimated 610,000 deaths in 2024; the WHO African Region accounted for about 95% of those deaths, and children under five made up about three-quarters of the deaths in that region, according to the World Health Organization.

The researchers, led by Professor Neta Regev-Rudzki, discovered that the parasite exports tiny vesicles containing messenger RNA (mRNA), not only into the red blood cells it infects, but also into the host’s monocytes — immune-system cells that should be helping to fight the infection. Once inside the monocyte, the parasite’s mRNA enters the cell nucleus and binds to two essential human proteins, ACIN1 and PNN, which are normally involved in cutting and splicing RNA transcripts so they can be translated into proteins. With this splicing machinery disrupted, crucial immune-related transcripts are misprocessed and degraded, suppressing the production of proteins needed for an effective immune response.

In other words, P. falciparum is not merely hiding from the immune system; it is actively sabotaging part of the host’s cellular communication network from inside the nucleus. The result is a neat evolutionary trick: the immune system is distracted and disrupted while the real threat — parasites multiplying inside red blood cells — continues to spread.

Plasmodium falciparum — An Evolutionary Success Story. Plasmodium falciparum is the single-celled parasite responsible for the most dangerous form of human malaria. It is not a bacterium or a virus, but a complex eukaryotic organism belonging to the apicomplexans — a group of parasitic protozoans that also includes the agents of toxoplasmosis and cryptosporidiosis.

Its life cycle depends on two hosts: humans and female Anopheles mosquitoes. The mosquito injects the parasite’s sporozoite stage into the bloodstream; these first invade liver cells, multiply silently, then emerge to infect red blood cells. It is this blood-stage infection that causes the fever, anaemia, organ damage and, in severe cases, cerebral malaria.

P. falciparum is especially dangerous because it can infect red blood cells of different ages and can reach very high parasite densities. Infected red cells also become sticky, allowing them to adhere to the walls of small blood vessels. This “sequestration” helps the parasite avoid clearance by the spleen but can obstruct blood flow in vital organs, including the brain.

Its origin is now understood in evolutionary terms. P. falciparum belongs to the Laverania group of malaria parasites that naturally infect African apes. Genetic studies show that the human parasite most likely arose when a gorilla malaria parasite crossed the species barrier into humans, probably in Africa, and then adapted to its new host.

The exact timing is still debated, but the important point is clear: P. falciparum was not specially created as a fixed, unchanging organism. It is the descendant of related ape parasites, shaped by mutation, selection, host-switching and adaptation. Its lethality is not evidence of benevolent design, but of an evolutionary arms race between parasite, mosquito and human immune system.

The work of the Weizmann Institute team is explained in a news release from the American Committee for the Weizmann Institute of Science:

Malaria’s mRNA: Messages that Mess with the Immune System
The deadly parasite uses its own messenger RNA to keep the host’s immune system jammed while it multiplies and spreads
RNA technology is regarded as one of the newest frontiers in medicine, but in fact a primordial innovator got there way before we did. The malaria parasite, an ancient single-celled organism, has been using sophisticated RNA maneuvers for millennia. In a study recently published in Cell Reports, researchers at the Weizmann Institute of Science uncover the parasite’s RNA strategies – mechanisms that could inspire unexpected applications for RNA-based tools in multiple areas of medicine.

More than a decade ago, Prof. Neta Regev-Rudzki discovered that the malaria parasite Plasmodium falciparum, which invades human red blood cells, sends out tiny vesicles to communicate with fellow parasites inside other red blood cells. These nanovesicles – wrapped, sac-like packages addressed to other cells – were shown to transfer pieces of DNA from one parasite to another. But Regev-Rudzki and her team found that the vesicles also contain other molecular cargo, including various types of RNA. 

The researchers reasoned that the clever parasite wouldn’t transport its RNAs via vesicles without good reason. In the new study, the team, in Weizmann’s Biomolecular Sciences Department, set out to determine whether the vesicles enable the RNAs to perform tasks beyond messaging. Because the team had previously shown that nanovesicles enter not only red blood cells but also immune cells called monocytes, the researchers suspected the parasite might be trying to mess with the host’s immune defenses. 

They soon learned that the parasite is even more devious than they had imagined. The team, led by Dr. Paula Abou Karam, then a PhD student, found that the RNAs in the vesicles were not random fragments but rather messenger RNA, or mRNA – specifically, molecules containing instructions for producing one of the parasite’s most abundant protein families. Could the parasites be inserting their own mRNA into the cells’ protein-making machinery in the cytoplasm? 

Contrary to expectations, there was no sign of the parasitic proteins they expected these RNAs to make in the cytoplasm of the monocytes. Instead, to the researchers’ surprise, the RNAs appeared to be entering the immune cells’ highly protected nuclei.

This seemed incredible. The cell guards its nucleus jealously because it houses the cell’s ‘brain.’ To convince ourselves – and others – that the parasite’s RNAs truly penetrate these defenses, we had to observe them directly inside the nucleus.

Professor Neta Regev-Rudzki, co-corresponding author.
Department of Biomolecular Sciences
Faculty of Biochemistry
Weizmann Institute of Science
Rehovot, Israel.

At first, this task seemed nearly impossible. Parasitic RNA molecules are present in extremely small amounts that are easily lost within the crowded nucleus. Another difficulty stemmed from the parasite’s genome itself, which is unusually repetitive, composed largely of just two genetic letters, A and T. Designing a method sensitive enough to detect the parasite’s RNAs amid all the host genetic material was thus a huge challenge. 

Sometimes what makes or breaks a research project is the student who leads it, and this was one of those classic cases. Paula took on the challenge, keeping at it for a year and a half until she ultimately succeeded.

Professor Neta Regev-Rudzki.

Abou Karam developed a fluorescent probe that caused minuscule red dots to light up inside the monocyte nucleus. Each dot represented a single malarial mRNA molecule that had breached the nuclear barrier.

The next question was: What were these RNAs doing there? The researchers discovered that once inside the nucleus, the parasite mRNA binds to two human proteins, ACIN1 and PNN – key components of the cellular splicing machinery. Like splicing film, cells use the splicing to edit RNA transcripts, cutting and rearranging segments before allowing them to be translated into proteins. It serves as a crucial quality-control step: Without proper splicing, RNAs do not “make sense,” and they are generally discarded before they can be translated into proteins. 

At this stage, the researchers joined forces with the team of Dr. Zeev Melamed of the Hebrew University of Jerusalem, an expert in splicing and RNA. Together, they revealed splicing manipulation in recipient monocytes, thereby deciphering the parasite’s RNA strategy.

Sabotage in the nucleus

In effect, the parasite jams the internal communications of the host’s immune system. By getting its mRNA into monocyte nuclei, it disrupts the host cell’s own RNA processing. The result is chaos. Critical immune transcripts – meant to produce proteins that fight infection – are improperly spliced and then sent off to be degraded. As a result, the production of entire families of immune proteins is shut down. 

As they continued to observe the immune cell takeover, the scientists found that the manipulated monocytes send out distress signals, triggering a wave of immune activation that mobilizes additional immune cells. But while these cells rush to deal with the apparent crisis inside the monocytes, the real threat – parasites quietly multiplying inside red blood cells – escapes attention.

Red alert, red herrings: Malarial RNA molecules (red dots) observed inside the nuclei (blue) of monocytes (green) using fluorescence confocal microscopy.

It’s a decoy mechanism. Like throwing a grenade in one direction so the guards run toward it, while you move somewhere else.

Professor Neta Regev-Rudzki.

By confusing immune cells and suppressing key defense proteins, the parasite buys itself precious time to grow and spread.

These findings point to a potential new target for antimalarial drugs – therapies designed to prevent malarial RNAs from tampering with the host’s splicing machinery.

The work may also open new avenues for diagnosis, not only of malaria but of other infectious diseases. Bilharzia parasites, for example, can reside in the gut for years, causing damage while remaining undetectable in standard blood tests. Regev-Rudzki believes that they, and other parasites, may be releasing vesicles whose RNA signatures in the bloodstream might reveal their presence.

The study’s implications extend far beyond infectious disease. Vesicles abound in the body and searching for their cargo not only in the cytoplasm, but in unexpected places such as the carefully guarded nuclei, can increase the chances of intercepting these packages and reading their messenger RNA. And that, in turn, might help us decipher disease-promoting mechanisms. The feints and strategies employed by cancer, for example, include the release of vesicles that influence surrounding healthy tissue. Vesicles are also an active area of research in Parkinson’s, ALS, and other neurodegenerative diseases. Vesicle-bound RNAs circulating in blood may one day serve as early biomarkers for these disorders. 

Also participating in the study were Edo Kiper, Shaked Yadid, Dr. Ewa Kozela, Nir Zharoni, Dr. Reinat Nevo, Daniel Alfandari, Helina Otesh, Abel Cruz Camacho, and Dr. Ofer Shoshani of Weizmann’s Biomolecular Sciences Department; Dr. Tamar Ziv of the Technion – Israel Institute of Technology; Dr. Yoav Lubelsky and Prof. Igor Ulitsky of Weizmann’s Immunology and Regenerative Biology Department; Drs. Ron Rotkopf, Ekaterina Petrovich-Kopitman, and Ziv Porat of Weizmann’s Life Sciences Core Facilities Department; Dr. Eviatar Weizman of the Nancy and Stephen Grand Israel National Center for Personalized Medicine; Moshe Cossin of the Hebrew University of Jerusalem; Dr. Irit Rosenhek-Goldian of Weizmann’s Chemical Research Support Department; and Prof. Carmit Levy of Tel Aviv University.

Publication:
Abou Karam, Paula; Kiper, Edo; Ziv, Tamar; Yadid, Shaked; et al.
Nuclear import of malaria RNA rewires splicing in host immune cells.
Cell Reports (2026) 45(2) DOI: 10.1016/j.celrep.2026.116953

Highlights

Plasmodium falciparum delivers three parasitic ETRAMP mRNAs into host monocytes via EVs
Delivered RNAs evade degradation, enter the protected host nucleus, and bind ACIN1/PNN
Host splicing dysregulation causes transcript misprocessing and altered immune response
An extracellular RNA-based mechanism shows how malaria reshapes host immune signaling

Summary
Eukaryotic pathogens deploy diverse strategies to manipulate host immunity, yet RNA-based virulence mechanisms remain poorly understood. We describe a mechanism by which the malaria parasite Plasmodium falciparum governs host immune responses through direct interference with host nuclear RNA processing. Malaria-encoded mRNAs of the early transcribed membrane protein family, exported from infected red blood cells, evade cytoplasmic degradation within host immune cells and are imported into their highly secured nuclei. Inside the nucleus, parasite transcripts bind the host RNA-binding proteins ACIN1 and PNN, key components of the splicing machinery that associate with the exon junction complex. This interaction disrupts host splicing regulation, leading to widespread misprocessing of transcripts and altered expression of proteins involved in immune function. Our findings uncover an RNA-based strategy by which pathogen-derived transcripts exploit the host splicing machinery, reshaping transcript isoform landscapes and immune signaling.
Graphical abstract

Abou Karam, Paula; Kiper, Edo; Ziv, Tamar; Yadid, Shaked; et al.
Nuclear import of malaria RNA rewires splicing in host immune cells.
Cell Reports (2026) 45(2) DOI: 10.1016/j.celrep.2026.116953

Copyright: © 2026 The authors.
Published by Elsevier Inc. Open access.
Reprinted under a Creative Commons Attribution 4.0 International license (CC BY 4.0)

And this is where the evidence becomes especially uncomfortable for Intelligent Design advocates. If Behe’s “irreducible complexity” and Dembski’s “complex specified information” are supposed to identify the handiwork of an intelligent designer, then Plasmodium falciparum should qualify almost perfectly. It has a complex life cycle involving mosquito and human hosts; it invades liver cells and red blood cells; it remodels infected cells to evade immune destruction; and now we know it can export mRNA-containing vesicles into immune cells and interfere with the host’s RNA-splicing machinery. This is not random biological clutter. It is highly organised, information-rich, target-specific molecular machinery.

The problem for Behe and Dembski, of course, is that this “design” is directed towards making people ill and, in hundreds of thousands of cases each year, killing them — most tragically, very young children. If their argument is that complex biological systems performing specific functions point to design, then consistency demands that malaria’s exquisitely efficient immune sabotage should be placed in the same category as the bacterial flagellum, the blood-clotting cascade and the vertebrate eye. They do not get to praise complexity when it looks useful or inspiring, then quietly ignore it when it comes packaged as a lethal parasite.

Evolution has no such problem. It predicts precisely this kind of outcome: a relentless arms race in which parasite and host are locked into reciprocal adaptation. Any mutation or genetic variation that helps the parasite invade cells, evade immunity, manipulate the host or increase transmission through mosquitoes can be favoured by natural selection. No benevolence is required. No foresight is needed. No cosmic morality is involved. Just differential survival and reproduction, accumulated over generations.

So, once again, the evidence points not to wise design, but to blind, amoral evolution. P. falciparum is not an embarrassment for Darwinian evolution; it is a textbook example of it. The embarrassment belongs to those who claim that intricate molecular machinery is evidence of their favourite designer — but only when they can avoid looking too closely at what that machinery actually does. But if creationists insist on a designer, they have to concede that the designer is a malevolent sadist who designs ways to increase suffering and misery.

Advertisement

Amazon